These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35483235)

  • 1. Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.
    Farhangnia P; Dehrouyeh S; Safdarian AR; Farahani SV; Gorgani M; Rezaei N; Akbarpour M; Delbandi AA
    Int Immunopharmacol; 2022 Aug; 109():108786. PubMed ID: 35483235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic.
    Dassarma B; Tripathy S; Matsabisa M
    Transfus Clin Biol; 2021 Feb; 28(1):123-127. PubMed ID: 33285298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.
    Bonam SR; Kaveri SV; Sakuntabhai A; Gilardin L; Bayry J
    Cell Rep Med; 2020 May; 1(2):100016. PubMed ID: 32562483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
    Strohl WR; Ku Z; An Z; Carroll SF; Keyt BA; Strohl LM
    BioDrugs; 2022 May; 36(3):231-323. PubMed ID: 35476216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
    Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
    BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
    Majumder J; Minko T
    AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection.
    Tabll AA; Shahein YE; Omran MM; Elnakib MM; Ragheb AA; Amer KE
    Hum Antibodies; 2021; 29(3):179-191. PubMed ID: 33998533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].
    Chen C; Zhang XR; Ju ZY; He WF
    Zhonghua Shao Shang Za Zhi; 2020 Jun; 36(6):471-475. PubMed ID: 32114747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible of immunotherapy for COVID-19: A systematic review.
    AminJafari A; Ghasemi S
    Int Immunopharmacol; 2020 Jun; 83():106455. PubMed ID: 32272396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
    Lindholm PF; Ramsey G; Kwaan HC
    Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent plasma and hyperimmune globulin therapy in COVID-19.
    Cagdas D
    Expert Rev Clin Immunol; 2021 Apr; 17(4):309-316. PubMed ID: 33620014
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent plasma in Covid-19: Possible mechanisms of action.
    Rojas M; Rodríguez Y; Monsalve DM; Acosta-Ampudia Y; Camacho B; Gallo JE; Rojas-Villarraga A; Ramírez-Santana C; Díaz-Coronado JC; Manrique R; Mantilla RD; Shoenfeld Y; Anaya JM
    Autoimmun Rev; 2020 Jul; 19(7):102554. PubMed ID: 32380316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.